<?xml version="1.0" encoding="UTF-8"?>
<p>Limited data are available regarding cancer survivors and the risk of SARS‐CoV‐2 infection. Considering the limited data, we continue to suggest that cancer survivors follow the recommendations found on the WHO and CDC websites for the general population 
 <xref rid="onco13306-bib-0035" ref-type="ref">35</xref>. Deferring or reducing surveillance visits may be considered to minimize exposure. Rescheduling these visits must be tracked to avoid patients being lost to follow‐up. Furthermore, routine screening appointments and genetics oncology clinics may be deferred until the pandemic wave is over; however, patients with abnormal screening results before or at the beginning of the pandemic should be assessed on a case‐by‐case basis.
</p>
